MedTrace Logo

Impact of Hybrid Coronary Revascularization on Antiplatelet Therapy

NCT02293928 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2014-11-19

No results posted yet for this study

Summary

The effect of antiplatelet therapy is impaired among patients, who recently underwent on-pump coronary artery bypass grafting. The impact of hybrid coronary revascularization using minimal invasive surgical techniques on the antiplatelet effect of aspirin and clopidogrel remains unclear.

The aim of the study is to describe the impact of hybrid coronary revascularization on the effect of aspirin and clopidogrel. Furthermore, we will investigate whether high baseline platelet aggregation, high postoperative levels of platelet turnover and acute-phase response may contribute to the effect.

Conditions

Interventions

PROCEDURE

Hybrid coronary revascularization

Hybrid coronary revascularization with standard double antiplatelet therapy

Sponsors & Collaborators

  • Danish Heart Foundation

    collaborator OTHER

  • Aase and Ejnar Danielsens Foundation

    collaborator OTHER

  • Aarhus University Hospital Skejby

    lead OTHER

Principal Investigators

  • Ivy S Modrau, MD, DMSc · Aarhus University Hospitak Skejby

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02293928 on ClinicalTrials.gov